Stead Impact Ventures Leads $15M Series A to Support MedWatch Technologies’ Mission to Advance Metabolic Wellness InnovationLAS VEGAS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- MedWatch Technologies today announced that Stead Impact Ventures has committed to lead its $15M Series A financing, supporting the company’s mission to advance metabolic wellness through the development of a non-invasive biosensor for glucose-related insight and an integrated lifestyle coaching platform (currently under development).
